BE462012A - - Google Patents
Info
- Publication number
- BE462012A BE462012A BE462012DA BE462012A BE 462012 A BE462012 A BE 462012A BE 462012D A BE462012D A BE 462012DA BE 462012 A BE462012 A BE 462012A
- Authority
- BE
- Belgium
- Prior art keywords
- methyl
- isopropyl
- allyl
- barbituric acid
- acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 5
- 150000001447 alkali salts Chemical class 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000003533 narcotic effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical class COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical class CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE462012A true BE462012A (https=) |
Family
ID=114531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE462012D BE462012A (https=) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE462012A (https=) |
-
0
- BE BE462012D patent/BE462012A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0316993B1 (fr) | Compositions pharmaceutiques contenant un dérivé de l'acide 3-hydroxybutanoique choisi parmi les oligomères de cet acide et les esters de cet acide ou de ces oligomères avec du 1,3-butanediol | |
| JPS60136512A (ja) | 脂質代謝改善剤 | |
| BE462012A (https=) | ||
| EP0601911A1 (fr) | Acylaminoacides obtenus par l'acylation d'hydrolysats de protéines et compositions anti-microbiennes, antiparasitaires ou cosmétiques en contenant | |
| TR201809354T4 (tr) | 5 alfa androstan (alkil) 3 beta,5,6 beta triol enjeksiyonu ve Bunun hazırlanmasına yönelik yöntem. | |
| FI92015C (fi) | Menetelmä injektoitavan, loistenvastaisen koostumuksen valmistamiseksi | |
| RU2372904C2 (ru) | Композиция альфа-липоевой (тиоктовой) кислоты, способ ее получения и способ лечения | |
| FR2542999A1 (fr) | Procede de fabrication de liposome contenant un ou plusieurs sterylglucosides et monopalmitates de sterylglucosides et nouveaux produits ainsi obtenus | |
| MC1485A1 (fr) | Procede de preparation de solutions aqueuses de sulfonamides potentialises | |
| FR2516923A1 (fr) | Nouveaux sels organiques du tetramisole et compositions pharmaceutiques les contenant | |
| NO334540B1 (no) | Fremgangsmåte for fremstilling av et parasiticid for utryddelse av parasitter hos oppdrettsfisk | |
| IE47985B1 (en) | Pharmaceutical compositions and their use in the prophylaxis and/or treatment of certain diseases | |
| FR2507891A1 (fr) | Medicament, notamment pour le traitement des maladies a virus du type herpes | |
| JPS5953423A (ja) | セフアロスポリン化合物含有直腸投与用製剤組成物 | |
| Moore et al. | On the chemistry and bio-chemical and physiological properties of a sapo-glucoside obtained from the seeds of Bassia longifolia (mowrah seeds) | |
| BE494334A (https=) | ||
| FR3120523B1 (fr) | Procédé d’incorporation d’eaux mères de marais salants dans des compositions cosmétiques, et compositions cosmétiques ainsi préparées | |
| CH167958A (fr) | Procédé de préparation d'une solution huileuse stable et stérilisable de mono-a-butylnormal thiolaurate de bismuth. | |
| CN121489861A (zh) | 一种依托考昔注射浓溶液及其制备方法 | |
| BE333357A (https=) | ||
| BE483963A (https=) | ||
| BE530472A (https=) | ||
| BE541013A (https=) | ||
| BE562589A (https=) | ||
| CH169591A (fr) | Procédé de préparation d'une solution huileuse stable et stérilisable de tri-a-butylnormal thiolaurate de bismuth. |